Press releases, scientific publications, executive appointments, and stories from our 118 markets. Every story is verified by meridians Global's communications office.
The trial enrolled 1,204 patients across 47 sites in 14 countries, demonstrating a 34% improvement in progression-free survival versus standard of care. Full results will be presented at the European Society for Medical Oncology congress in October.
Meridian's latest trial demonstrates significant improvement in patients with previously untreatable conditions.
The five-year agreement expands Cultiva's cover-crop and no-till programs across Kenya, Tanzania, and Zambia.
Meridian now sources 92% of electricity from renewable sources across its global operations.
Dr. Barbier joins from the Institut Pasteur, where she led the global RNA therapeutics program.
Our contraception and hormone therapy platforms now reach patients in 94 countries.
Average yield uplift of +27% in low-rainfall years, according to independent field trials.
New watershed partnerships in Brazil and India will restore 12,000 hectares of riparian zones.
The 42,000 m² facility will house 1,200 scientists working on AI-guided drug discovery and regenerative agriculture.
Meridian's generative chemistry platform has reduced target-to-lead time from 14 months to 11 days.
No stories match your filter.
Every story in the meridians Global newsroom is verified by our communications office before publication. We cite sources, disclose executive affiliations, and correct the record openly when needed.